Guido J. Neels's most recent trade in Elutia Inc - Ordinary Shares - Class A was a trade of 106,393 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elutia Inc (Class A) | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 106,393 | 106,393 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 17,550 | 17,550 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 17,335 | 17,335 | - | - | Stock Option (Right to Buy) | |
| TELA Bio Inc | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 11,925 | 11,925 (0%) | 0% | 0 | Common Stock | |
| TELA Bio Inc | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 11,675 | 23,600 (0%) | 0% | 0 | Common Stock | |
| Bioventus Inc (Class A) | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2026 | 32,282 | 117,523 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc (Class A) | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2026 | 32,282 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2026 | 25,146 | 25,146 | - | - | Restricted Stock Units | |
| Elutia Inc (Class A) | Guido J. Neels | Director | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 30 Jan 2026 | 20,000 | 118,750 | - | 1.0 | 20,800 | Class A Common Stock |
| Elutia Inc (Class A) | Guido J. Neels | Director | Purchase of securities on an exchange or from another person at price $ 1.06 per share. | 28 Jan 2026 | 15,000 | 83,750 | - | 1.1 | 15,900 | Class A Common Stock |
| Elutia Inc (Class A) | Guido J. Neels | Director | Purchase of securities on an exchange or from another person at price $ 1.06 per share. | 28 Jan 2026 | 15,000 | 98,750 | - | 1.1 | 15,900 | Class A Common Stock |
| Elutia Inc (Class A) | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2025 | 6,250 | 0 | - | - | Restricted Stock Units | |
| Elutia Inc (Class A) | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2025 | 6,250 | 125,000 | - | - | Class A Common Stock | |
| Elutia Inc (Class A) | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 6,250 | 0 | - | - | Restricted Stock Units | |
| Elutia Inc (Class A) | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2025 | 6,250 | 68,750 | - | - | Class A Common Stock | |
| Elutia Inc (Class A) | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2025 | 171,916 | 171,916 | - | - | Stock Option (Right to Buy) | |
| Axogen Inc | Guido J. Neels | Director | Sale of securities on an exchange or to another person at price $ 10.61 per share. | 09 Jun 2025 | 4,073 | 86,743 (0%) | 0% | 10.6 | 43,215 | Common Stock |
| Bioventus Inc (Class A) | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 32,282 | 32,282 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 26,493 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 26,493 | 85,241 (0%) | 0% | 0 | Class A Common Stock | |
| Axogen Inc | Guido J. Neels | Director | 01 Sep 2024 | 11,904 | 90,816 (0%) | 0% | 0 | Common Stock | ||
| Axogen Inc | Guido J. Neels | Director | 01 Sep 2024 | 11,904 | 0 | - | - | Restricted Stock Units | ||
| Bioventus Inc (Class A) | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 26,493 | 26,493 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 30,400 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 30,400 | 58,748 (0%) | 0% | 0 | Class A Common Stock | |
| Axogen Inc | Guido J. Neels | Director | 06 Jun 2024 | 18,248 | 18,248 | - | - | Employee Stock Option (right to purchase) | ||
| Axogen Inc | Guido J. Neels | Director | 06 Jun 2024 | 10,653 | 78,912 (0%) | 0% | - | Common Stock | ||
| Axogen Inc | Guido J. Neels | Director | 16 Aug 2023 | 10,000 | 68,259 (0%) | 0% | 6.1 | 61,100 | Common Stock | |
| Bioventus Inc (Class A) | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,400 | 30,400 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 16,648 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 16,648 | 28,348 (0%) | 0% | 0 | Class A Common Stock | |
| Axogen Inc | Guido J. Neels | Director | 01 Jun 2023 | 6,459 | 58,259 (0%) | 0% | 0 | Common Stock | ||
| Axogen Inc | Guido J. Neels | Director | 01 Jun 2023 | 6,459 | 0 | - | - | Restricted Stock Units | ||
| Bioventus Inc (Class A) | Guido J. Neels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 16,648 | 16,648 | - | - | Restricted Stock Units | |
| Axogen Inc | Guido J. Neels | Director | 01 Jun 2022 | 11,811 | 11,811 | - | - | Stock Option (right to purchase) | ||
| Axogen Inc | Guido J. Neels | Director | 01 Jun 2022 | 6,459 | 6,459 | - | - | Restricted Stock Units | ||
| Axogen Inc | Guido J. Neels | Director | 01 Jun 2022 | 3,036 | 51,800 (0%) | 0% | 0 | Common Stock | ||
| Axogen Inc | Guido J. Neels | Director | 01 Jun 2022 | 3,036 | 0 | - | - | Restricted Stock Units | ||
| Bioventus Inc (Class A) | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 2,700 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 2,700 | 11,700 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc (Class A) | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 9,000 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc (Class A) | Guido J. Neels | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 9,000 | 9,000 (0%) | 0% | - | Class A Common Stock |